Ma, Hehua
Hong, Yuxin
Xu, Zhi
Weng, Zuyi
Yang, Yuanxun
Song, Wei https://orcid.org/0000-0003-3756-198X
Li, Juan
Funding for this research was provided by:
National Natural Science Foundation of China (82002984)
National Natural Science Foundation of China (31371399)
Natural Science Foundation of Jiangsu Province (BK20200119)
Nanjing Health Technology Development Project (YKK24079)
Anhui Province Key Laboratory of Translational Cancer Research (KFDX202201)
Open Project of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment (KFKT202506)
Article History
Received: 28 September 2025
Revised: 24 April 2026
Accepted: 27 April 2026
First Online: 7 May 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. For HCC patient specimens, the approval was granted by the Institutional Ethics Committee of Nanjing Drum Tower Hospital (No. 2024–356-03). The animal experiments were approved by the Ethics Committee of Nanjing First Hospital and carried out under the guidance of the Animal Experiment Center of Nanjing First Hospital (No. DWSY-24089545).
: Not applicable.
: The authors have no competing interests to declare.